Baylor College of Medicine

Technology Development for non-invasive prenatal genetic diagnosis using maternal peripheral blood (H-24326)

Description

Content

Study Goal(s): Development and validation of new methods to diagnose genetic diseases in the fetus by studying cells and fetal DNA in the mother's blood.

Eligibility Criteria: Pregnant women over 18 years old who have prenatal diagnosis by amniocentesis or chorionic villus sampling

Investigators: Ignatia Van den Veyver, M.D. (principal investigator)

Supported by: Baylor College of Medicine

NIH Contact: nipdstudy@bcm.edu

Contact

Ignatia B. Van den Veyver

Phone 1: 832–824–8125

IRB: H-24326

Status:

Active

Created:

Back to topback-to-top